首页> 外国专利> Inhalation bronchography X:ray contrast agents - contg. poorly soluble esp. calcium salts of dicarboxylic acid iodinated dianilide derivs.

Inhalation bronchography X:ray contrast agents - contg. poorly soluble esp. calcium salts of dicarboxylic acid iodinated dianilide derivs.

机译:吸入支气管造影X:射线造影剂-续。易溶的,特别是二羧酸碘化二苯胺的钙盐衍生。

摘要

New X-ray contrast agents contain as radiopaque substance a dicarboxylic acid dianilide of formula (I): (where X is 1-10C alkylene opt. interrupted by O-atoms) in the form of a poorly soluble, powdery salt. The calcium salts of cpds. (I) (e.g. of 3,6-dioxa-suberic acid bis(2,4,6-triiodo-3-carboxyanilide) are claimed as novel cpds. Also claimed is the magnesium salt of 4,7,10,13-tetraoxahexadecane-1,16-dioyl bis(3-carboxy-2,4,6-triiodoanilide). The powdery, poorly soluble salts of (I) can be obtd. in the form of powders of particle ca 2-50 (pref. 3-20)mu m, which can be administered by inhalation without the need for intubation. The salts do not give rise to intolerance reactions in the bronchial system, and form a uniform radiopaque layer in the bronchial system without flowing into the alveolus. The salts are eliminated from the bronchial system within 24 hrs., by transport back into the throat and/or on account of their (slight) water-solubility.
机译:新的X射线造影剂含有不溶性粉状盐形式的不透射线的物质,式(I)的二羧酸二苯胺:(其中X是1-10C亚烷基,被O-原子中断)。 cpds的钙盐。 (I)(例如3,6-二氧杂酸双(2,4,6-三碘-3-羧基苯胺))被认为是新型cpds,还被要求保护4,7,10,13-四氧六十六烷的镁盐-1,16-二芳基双(3-羧基-2,4,6-三碘代苯胺)。(I)的粉状难溶盐可以颗粒ca 2-50的粉末形式存在(优选3) -20μm,可通过吸入给药而无需插管,这些盐不会在支气管系统中引起不耐受反应,并且在支气管系统中形成均匀的不透射线的层而不会流入肺泡。通过运回喉咙和/或由于其(轻微)水溶性,在24小时内将其从支气管系统中清除。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号